Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,126 | 1,559 | 2,543 | 3,958 | 3,866 |
| TOTAL | $1,253 | $1,671 | $2,727 | $4,072 | $4,041 |
| Non-Current Assets | |||||
| PPE Net | 6,788 | 6,834 | 6,983 | 7,172 | 7,366 |
| Intangibles | 315 | 317 | 319 | 321 | 323 |
| Other Non-Current Assets | 2 | 3 | 3 | 6 | 10 |
| TOTAL | $7,105 | $7,153 | $7,305 | $7,499 | $7,699 |
| Total Assets | $8,357 | $8,824 | $10,032 | $11,571 | $11,741 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,156 | 1,281 | 1,166 | 1,119 | 1,349 |
| Accrued Expenses | 26 | 26 | 33 | 65 | 283 |
| TOTAL | $1,182 | $1,307 | $1,199 | $1,184 | $1,633 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,182 | $1,307 | $1,199 | $1,184 | $1,633 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,997 | 17,431 | 16,072 | 15,641 | 14,347 |
| Retained earnings | -150,627 | -148,842 | -146,746 | -144,529 | -142,502 |
| TOTAL | $7,175 | $7,518 | $8,833 | $10,387 | $10,108 |
| Total Liabilities And Equity | $8,357 | $8,824 | $10,032 | $11,571 | $11,741 |